REG - Luceco PLC - Market Purchase of Shares for EBT

LucecoAnnouncement

13/02/2025 14:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250213:nRSM0646Xa&default-theme=true

RNS Number : 0646X  Luceco PLC  13 February 2025

 

Luceco plc

(the "Company")

 

Luceco plc announces market purchase of shares for its Employee Benefit Trust

 

Luceco Plc (Luceco or the Company) was notified by Apex Financial Services
(Trust Company) Limited (Apex), acting as trustee of the Luceco plc Employee
Benefit Trust (the Trust), that Apex purchased in the market a total of
2,000,000 Luceco ordinary shares with a nominal value of £0.0005 each
(Shares) as set out in the table below.

 

The Trust holds the Shares for the purpose of satisfying awards to be awarded
to beneficiaries of the Trust. The executive directors and persons discharging
managerial responsibility on behalf of the Company are potential beneficiaries
under the Trust and are therefore treated as having an interest in such
Shares. Upon settlement of the above transaction, the Trust will hold a total
of 10,229,865 Shares, representing 6.36% of Luceco's issued ordinary share
capital.

 

 

 Number of shares  Transaction price  Date of transaction

purchased
(per share)
 760,000           1.5277             31.01.2025
 990,000           1.5835             07.02.2025
 250,000           1.585              10.02.2025

 

 

13 February 2025

LEI: 213800BBFZK4W4P98U76

- ENDS-

 

 For further information please contact:
 Luceco plc                          via the Company Secretary, MUFG Corporate Markets

 Will Hoy, Chief Financial Officer   0333 300 1932 (via MUFG Corporate Markets)

 MUFG Corporate Markets              0333 300 1932

 Michael Conway

 Paris Condon

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHSFWFLDEISESE